AGP Executive Report

Precision Medicine Rollout: Tempus launched national OneOme pharmacogenomics testing, adding 27-gene and single-gene options to help clinicians gauge medication safety, dosing, and toxicity risk. Digital Health Leadership: WHOOP named cardiologist Dr. Ami Bhatt as Chief Medical Officer to steer its consumer health push with clinical and AI oversight. Policy & Access: The U.S. House passed Energy and Commerce bills aimed at reauthorizing public health programs, expanding workforce support, and speeding access to medical innovation. Medication Safety: FDA flagged a cetirizine recall after cross-contamination with ranitidine, warning of potentially life-threatening reactions for some allergy sufferers. Medicaid Shockwaves: Multiple reports highlight Medicaid payment freezes and fraud crackdowns, while Kentucky Gov. Beshear moved $255M in surplus funds to prevent a 4% cut. Global Supply & Trade: Trump’s proposed steep generic-drug tariffs from 2028 rattled Indian pharma, with analysts warning of higher costs and export pressure. Health Systems Capacity: Zimbabwe’s China-aided National Pharmaceutical Warehouse is boosting storage and distribution since 2022.

Medicaid Crackdown: HHS is freezing more than $1B in Medicaid payments to California and Minnesota over suspected fraud and documentation gaps, with states facing demands for proof before funds are released. Work Requirements Pressure: North Dakota is preparing to apply 80-hours-per-month work rules to some Medicaid Expansion adults starting Jan. 2027, with thousands potentially affected. Hospital Funding Fight: Texas children’s hospitals are urging CMS to reconsider proposed Medicaid rules they say could slash access to lifesaving pediatric care. Nursing Contract Tension: Thousands of Boston Medical Center nurses plan pickets over wages, insurance costs, and staffing strain, pushing for a new union contract. Drug Pricing Politics: A new Public Citizen argument says Medicare should negotiate drug prices at launch to prevent manufacturers from setting high initial prices and raising them repeatedly. Generic Drug Tariffs: Trump’s plan for steep tariffs on imported generics (100% from Aug 2028, up to 200% later) is already drawing warnings about higher medicine costs. Fraud and Enforcement: A Coeur d’Alene doctor was sentenced in a Medicare fraud case tied to telemedicine genetic tests and braces; separately, an FBI capture ended a years-long hunt for a fugitive accused in a $547M Medicare scheme. Safety Alerts: A cetirizine allergy medicine recall is underway after contamination concerns involving ranitidine. Global Health Aid: India delivered the first 4.5 tonnes of Ebola-related medical supplies to Kenya to strengthen preparedness.

Medicaid Crackdown: The Trump administration is deferring more than $1B in Medicaid payments to California and Minnesota over suspected fraud and “noncompliance,” drawing sharp pushback from lawmakers and advocates who warn it could disrupt care for vulnerable seniors. Drug Pricing & Supply: Trump announced steep phased tariffs on imported generic medicines—0% for two years starting Aug 1, 2026, then 100% and 200%—a move aimed at reshoring manufacturing that could hit India, a major generic exporter. GLP-1 & Alcohol Use Disorder: A BMJ Open study links newer GLP-1 drugs (semaglutide or tirzepatide) to fewer alcohol-related hospital admissions in adults with alcohol-use disorder. Health Equity in Admissions: Federal investigators opened a civil rights probe into East Carolina University’s medical school admissions for alleged racial discrimination. Community Care Access: Niagara Falls Memorial Medical Center will expand outreach with Niagara Pride via a monthly mobile health unit. Public Health Alert: FDA is still investigating the cyclosporiasis outbreak after earlier test results were a false positive, while local health officials urge food and hygiene precautions. New Treatments in the Pipeline: Nature Medicine reports promising safety/tolerability results for personalized allele-selective antisense oligonucleotides in SCN2A-related disease, and Lancet Gastroenterology & Hepatology publishes rapid biomarker improvements at 12 weeks for zabopegdutide in MASLD/MASH. Pharmacy Safety: A nationwide allergy medication recall was issued over possible cross-contamination that could trigger life-threatening reactions.

Weight-loss ad lawsuit: Novo Nordisk is suing Eli Lilly over “false and materially misleading” weight-loss and diabetes ads, accusing Lilly of using outdated study comparisons and burying key context. Policy & access: Spain’s Council of Ministers approved a draft Medicines and Health Products law that changes how medicines are financed and aims to reduce supply shortages. Counterfeit/food safety: The U.S. FDA and CDC are tracking a cyclospora outbreak tied to shredded iceberg lettuce from Taylor Farms, after a prior positive test was later deemed a false alarm; Michigan reports thousands of cases. Clinical trial progress: Envoy Medical says all 56 patients hit the three-month milestone in its pivotal Acclaim cochlear implant trial as it works toward an FDA PMA submission. Healthcare business moves: Fresenius Medical Care launched TherapyWise Analytics to help clinicians optimize kidney replacement therapy using cloud-based insights. Community health: Azerbaijan repatriated 16 people from Syria and provided initial medical and psychosocial support. Care delivery expansion: CVS will now dispense select pet prescriptions at thousands of stores. Global health workforce: BRICS nations agreed to create a working group on traditional, complementary and integrative medicine.

Biotech Deal: Samsung Biologics is set to buy Swiss peptide maker PolyPeptide for about $1.8B, aiming to expand into peptide therapies and GLP-1 manufacturing. Medicare Policy Fight: A Senate vote kept Washington’s AI-based Medicare coverage pilot (WISeR) running, despite claims it could deny care. Oncology Research: UT Southwestern and UAB report a strategy where pretreating glioblastoma with EGFR inhibitors before temozolomide made tumors far more sensitive in lab and mouse models. Gene Therapy Milestone: The FDA expanded CRISPR gene therapy Casgevy for sickle cell disease to children as young as 2. Diabetes Breakthrough: A stem-cell approach in mice reversed newly diagnosed Type 1 diabetes by reprogramming the immune system. Public Health Watch: El Paso is investigating seven cyclosporiasis cases tied to explosive diarrhea, with no single source yet identified. Healthcare Access & Safety: DOJ says UC San Diego medical school used an unlawful “shadow application” process favoring race in admissions. Workforce & Training: UVM Medical Center earned an ANCC Well-being Excellence Credential for employee-driven wellbeing efforts.

Regulatory Watch: India’s CDSCO has approved QDENGA, Takeda’s dengue vaccine, for ages 4–60—an important step as dengue cases and deaths remain high. Policy & Access: Wisconsin begins implementing a law extending postpartum Medicaid coverage from 60 days to a year, aiming to reduce gaps in care and prevent avoidable deaths. Clinical Breakthrough: A Michigan Medicine-led trial found a daily heart-failure polypill improved cardiac function and cut hospital/ER visits by 60%, published in Nature Medicine. Public Health & Outbreak Response: WHO is enrolling its first treatment trial for the Bundibugyo Ebola strain in Congo, testing MBP-134 and remdesivir. Healthcare Systems & Safety: South Dakota’s rural EMS funding fight escalates as Rapid City’s fire department warns it may stop covering rural areas after 2026 without new funding. Pharma & Industry: Samsung Biologics announced a CHF 1.46B acquisition of PolyPeptide to scale peptide manufacturing, targeting growing demand tied to obesity and diabetes therapies. Medical Ethics & Courts: India’s Delhi High Court orders Safdarjung Hospital to file Sonam Wangchuk’s medical reports and will decide Tuesday on a request to move him to a private facility.

Chinese Medicine Global Push: Hong Kong’s ICMCM conference (Aug 13–15) is drawing international experts to speed “clinical translation” and expand Chinese medicine’s global reach. Pakistan–China Pharma Links: Officials highlight new Sino-Pak cooperation structures to boost herbal and TCM research, training, and innovation. COVID Update (India): Andhra Pradesh reports a fresh uptick and points to a home-based protocol from 2021 that cut hospitalisations in mild cases; meanwhile Maharashtra sees rising, mostly mild cases after years of low activity. Neonatal Care Tool: Doctors in Jaipur report that the CRIB-II score can quickly flag high-risk premature newborns and guide early treatment. Medicinal Cannabis Oversight (NZ): A Canterbury supplier faces charges after police allege cannabis use outside licence terms. Drug Access (Pakistan): About 40 registered medicines remain unavailable due to pending price approvals, pushing patients toward costly imports. Medicare Costs (US): New reporting explains how Roth conversions can trigger higher Medicare premiums via the IRMAA “two-year lookback.” Healthcare Equity (US): The EEOC sues UT Medical Branch over alleged equal-pay violations. Medical Devices Safety: A new investigation spotlights serious flaws in how some consumer medical devices are sold and regulated, including reported burns.

HIV Supply Chain: The Philippines’ DOH cleared the first rollout batch of 455,188 bottles of LTD (lamivudine/tenofovir/dolutegravir) after quality checks, aiming to keep treatment steady despite shipping disruptions. Primary Care Push: Tanzania health experts renewed calls to formally recognize Family Medicine in the public service system to ease hospital congestion and strengthen primary care. Cancer Care Logistics: An all-oral AML regimen (oral decitabine/cedazuridine plus venetoclax) is reducing infusion-center injection burdens, though patients still need frequent visits. Cancer Access Disruption: Nepal’s Sushil Koirala Prakhar Cancer Hospital faces a near three-month radiotherapy shutdown after a LINAC failure, forcing patients to travel to India. Drug Safety & Fraud: Uttarakhand authorities busted a counterfeit medicine unit, seizing about one lakh tablets and thousands of syrups; one suspect was arrested. Tech in Healthcare: Qatar’s Hamad Medical Corporation is accelerating digital lab systems to speed secure results and cut turnaround times. AI & Consumer Search: seenai reports many U.S. medical spas are missing from AI assistant recommendations, pushing “answer engine optimization” to get named directly. Medication Access & Cost: Medicare’s telehealth coverage guidance and new GLP-1 coverage rules are raising questions about eligibility and real-world access. Public Health Tech: Malaysia plans drone medicine delivery pilots in Tawau to reach rural villages with fewer travel barriers. Clinical Trial Ethics: India’s ICMR and NMC invited proposals to strengthen medical education quality through evidence-based innovations.

Retina Care Access: ASRS modeling links step-therapy rules for Vabysmo (faricimab) in diabetic macular edema to treatment delays and added burdens, with big variability across Medicare Advantage plans. Health Equity in Specialty Clinics: Another ASRS study finds retina-only practice dismissals skew younger, male, and from lower-income areas, with noncompliance driving most dismissals. Medicare Costs Surprise: A case study highlights how realized stock gains can trigger Medicare IRMAA surcharges two years later—long after the money is spent. Humanitarian Medicine: UAE’s “Gallant Knight 3” delivered a new WHO convoy of medicines and supplies to support Gaza hospitals, including priority kidney treatments. Protest Health Under Scrutiny (India): Safdarjung Hospital reports worsening metabolic markers for activist Sonam Wangchuk during a hunger strike, as legal and consent disputes continue. Medicaid in Jails: Santa Barbara County’s jail contractor expanded medication-assisted treatment, with more patients enrolled and fewer overdoses reported. Emergency System Planning (Qatar): A review in Qatar Medical Journal credits integrated emergency medicine planning and workforce training for better crisis-ready care. Public Health: Nigeria’s rabies alert urges mass pet vaccination and fast post-bite treatment after confirmed cases and deaths in FCT.

Patient Consent Clash in India: Climate activist Sonam Wangchuk was shifted to Safdarjung Hospital after a 21-day hunger strike, but his wife says doctors are withholding reports and that no oral or IV treatment should happen without family consent. Regulation & Access: Germany’s reproductive medicine rules are being called “shockingly unjust” for limiting infertility treatment coverage to married couples. Drug Enforcement: Telangana’s Drugs Control Administration seized unlicensed medicines worth about ₹18,000 in Hyderabad, including antibiotics, and sent samples for analysis. End-of-Life Governance: Maharashtra issued a framework for private hospitals to set up primary and secondary medical boards to review living-will decisions and withdrawal of life-sustaining treatment. Healthcare Policy Pressure (US): HHS denied it’s abandoning a rule that would restrict Medicaid/Medicare funding for hospitals providing transgender surgery to minors. Global Pharma & Safety: African Medicines Agency and Medicines for Africa partnered to strengthen public communication against substandard and falsified medicines. Public Health Practicalities: Britain’s MHRA warned holidaymakers that heat can weaken medicines and urged travelers to store treatments correctly and pack enough for trips.

Medicare Shake-Up: The Trump administration’s proposed 2027 Medicare physician payment changes aim to steer reimbursement toward prevention and primary care, with major implications for clinicians and the 70M+ people on Medicare. Medicaid Pressure: Kentucky families and advocates rallied against a planned 4% cut to Medicaid waiver reimbursement rates, warning it could shrink services for people with disabilities. Access & Safety in Focus: A Fort Worth dental office faced scrutiny after investigators found unsafe medication practices tied to a child’s death; meanwhile, PeaceHealth is temporarily adding valet help as ER parking closes during construction. Cancer & Drug Supply: Ifosfamide joins a growing list of chemo drugs in shortage, while Incyte plans multiple ESMO 2026 oral presentations on investigational oncology therapies. Global Health & Policy: Pakistan and China signed about $440M in pharma/healthcare deals, and Qatar’s emergency medicine system is highlighted as a model of centralized, specialty-led development. Public Health Alerts: Gaza reports ~5,000 weekly chickenpox cases amid vaccine shortages, and the Philippines’ DOH reassures the public that albendazole deworming is generally safe.

Medicare Policy: CMS proposed changes that could let approved Medicare ACOs reduce or eliminate some Part B cost-sharing starting in 2027, aiming to reward coordinated care over fee-for-service incentives. Medicaid & Access: Nurses in Michigan’s Ironwood rallied over federal Medicaid changes, warning that work requirements and more frequent eligibility checks could disrupt care for people in mental health crises. Prior Authorization Fight: Senate Republicans backed keeping the WISeR prior-authorization model despite claims it relies on AI to slow or deny care. Clinical Safety & Public Health: New York issued an air quality advisory as wildfire smoke returns, with doctors warning higher risk for asthma, chronic lung disease, and heart patients—especially in hot weather. Healthcare Governance: India’s NMC warned medical colleges not to admit beyond approved MBBS seats for 2026–27. Trials & Pharma Deals: Jasper Therapeutics closed its all-stock acquisition of Kira Pharmaceuticals in a $132M deal, expanding an immunology pipeline. Cancer Drug Affordability: India’s Supreme Court took suo motu notice of a Kerala case over exorbitant patented cancer drug prices after the patient died, ordering fast disposal. Workforce & Operations: UVM Health named Marc Kosak president and COO of Central Vermont Medical Center, focusing on access, quality, and community-based services.

Hospital Leadership: University of Vermont Health–Central Vermont Medical Center named Marc Kosak as its next president and COO, aiming to boost access, quality, safety, and workforce development. Pharmacy Access: Alaska’s new law expands what qualified pharmacists can treat and manage, targeting faster care for rural communities. Medicare & Policy: The U.S. Senate voted to block a repeal of CMS’s WISeR AI prior-authorization pilot, keeping the controversial model in place. Clinical Care in Real Life: New retina specialist data show many patients become “nonpersistent” with anti-VEGF injections over time, raising concerns about real-world treatment gaps. FDA & Drugs: The FDA approved Lipfendra, a new daily pill for high cholesterol, offering an oral option in the PCSK9 inhibitor class. Public Health & Safety: Georgia will require criminal background checks for pharmacy license applicants starting Oct. 1, 2026. Global Health: Lebanon’s “war medicine” efforts highlight ongoing attacks on healthcare workers and facilities.

Medicare GLP-1 access: CMS’s new “GLP-1 Bridge” pilot (starting July 1) lets eligible Medicare enrollees qualify for weight-loss drugs with a $50 monthly copay, using BMI and health-condition criteria plus prior authorization. Medicaid paperwork pressure: A new analysis warns that Medicaid “still eligible” renewals can still kick people off due to missed notices and documentation gaps, even when income hasn’t changed. Pharma legal fallout: Glenmark reached a nearly $30M settlement with Oregon and other states over alleged price-inflation and competition limits, with possible compensation for certain buyers. Hospital leadership moves: University of Vermont Health named Marc Kosak president and COO of Central Vermont Medical Center, aiming to boost access, quality, and workforce development. Pharmacy operations tech: TJM Labs launched “Vaccine Bot” to automate vaccination admin steps in pharmacies while keeping pharmacists in control. Global health & conflict: Israeli strikes in Gaza killed at least five Palestinians, according to medics and health officials. Clinical innovation: Clearmind Medicine reported improved intranasal MEAI nasal retention in ex vivo results, targeting Alcohol Use Disorder treatment delivery.

Medicare Overhaul: CMS proposed major 2027 Medicare physician payment changes, including conversion-factor cuts and a shift in quality reporting/value-based care—sparking pushback from physician groups. Medicare Advantage Scrutiny: Senators Blumenthal and Hawley pressed UnitedHealthcare and rivals over AI-linked prior authorization denials for post-hospital rehab. Medicaid Crackdown: Iowa launched a Medicaid Fraud Elimination Task Force, while Nevada rolled out new Medicaid work requirements starting Jan. 1, 2027. Access & Care Delivery: Maui Health and Mauliola Pharmacy expanded bedside discharge delivery (“Meds to ER” and “Meds to Beds”) to reduce post-discharge medication problems. Cancer Care Expansion: UChicago Medicine’s freestanding cancer center is set to open in April 2027. Drug & Tech News: Insilico Medicine and Bora Pharmaceuticals announced a strategic AI drug-discovery alliance valued up to $2.5B. Public Health & Safety: Extreme heat warnings highlighted risks for people on psychiatric meds, and a bee-sting “apitherapy” discussion resurfaced for arthritis pain. Workforce Pipeline: Idaho debated using rural health funds to expand medical residency build-out, and Delaware advanced plans for its first medical school (class in 2028).

Cold-Chain Stress Test: The NHS is preparing to move a new gene-therapy gel, Vyjuvek, which must be stored at ultra-cold temperatures and tracked precisely to keep patients safe. Medicaid Transparency Push: As work requirements loom, California and other states are pushing to publicly name big employers with workers on Medicaid, arguing it’s about fairness and shifting costs to taxpayers. Workforce Strain in Public Care: Malaysia reports 3,511 medical officers quit its public system from 2023–2025, with officials pointing to pay and career incentives as the main retention tools. Cybersecurity in Clinics: Australia’s Partnered Health says a major hack may have exposed patient records across its GP and skin cancer network, and patients are being contacted. Generic vs Innovator Spending: Malaysia’s MOH says generics dominated 2025 medicine procurement (RM3.01B; 77.88%), disputing claims that innovator spending was higher. Shelter Expansion: Canada’s federal funding helped expand Medicine Hat’s Phoenix Safe House, adding bedrooms and capacity for women in crisis. Pharma Deal/Access: Septa Pharmaceuticals acquired CeeNU (lomustine) from Bristol Myers Squibb to strengthen Canada oncology supply. Clinical Pipeline Updates: Tonix published new mpox clade findings in Journal of Virology, while aTyr shared Phase 3 sarcoidosis subgroup data and aTyr/aTyr-linked programs continue advancing.